The Right RIA For You. All content copyrighted © 2019 – onwards by Ambastha Financial LLC.
By Kuldip K. Ambastha On Friday, March 3, 2023, the stock price of Samsara Inc. (IOT), an American Internet of Things (IoT) company focused on the industrial sector, surged by +15.4% per share. From the perspective of revenues, the latest quarter and full-year figures disclosed came in higher than Wall Street expected. Samsara has seen …
By Kuldip K. Ambastha The stock price of Innovative Industrial Properties, Inc. (IIPR), an American real estate investment trust (REIT) focused on specialized properties rented out to state-licensed cannabis facilities through sale-leaseback agreements, fell by -16.9% per share on the trading day of Thursday, January 19, 2023. Investors were disappointed in the results disclosed by …
Continue reading “What Caught Our Attention in the Investment World? – Week of January 17-20, 2023”
By Kuldip K. Ambastha The stock of BeiGene, Ltd. (BGNE), a commercial stage biopharmaceutical company focused on cancer treatment drugs, saw a +20.5% increase in price per share on Wednesday, October 12, 2022. Brukinsa (zanubrutinib) in its Phase 3 trial data showed highly positive results in people with chronic lymphocytic leukemia (CLL) or small lymphocytic …
Continue reading “What Caught Our Attention in the Investment World? – Week of October 10-14, 2022”
By Kuldip K. Ambastha The stock of Regeneron Pharmaceuticals, Inc. (REGN), a biotechnology company with a portfolio of medicines for individuals with serious diseases, increased in price by +18.8% per share on the trading day of Thursday, September 8, 2022. Eylea (aka: aflibercept), an anti-blindness eye medication, was the cause of this price run-up, because …
Continue reading “What Caught Our Attention in the Investment World? – Week of September 6-9, 2022”
By Kuldip K. Ambastha Longeveron Inc. (LGVN), a biotechnology company focused on clinical stage therapies, had its stock price rise by +105.4% per share on Thursday, March 31, 2022. On this trading day, a great piece of news led to a great return. Lomecel-B has shown positive results from its Phase 1 trial testing on …
By Kuldip K. Ambastha Alphabet Inc. (GOOG), the parent company of Google, was a star performer on Wednesday February 2, 2022 when its stock delivered a +7.4% return for the trading day. The company’s earnings and revenue figures for the latest reporting quarter exceeded expectations. Furthermore, the company also announced a 20-for-1 stock split which …
By Kuldip K. Ambastha On Friday, September 3, 2021, the stock of Forte Biosciences, Inc. (FBRX) stood out for its substantial trading day loss of -82.3%. Forte Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on potential treatments for inflammatory skin diseases. The company released results of a Phase 2 clinical trial of FB-401, related …
By Kuldip K. Ambastha Biogen Inc. (BIIB), a biotech company, had a memorable Monday of this past trading week. On Monday, June 7, 2021, Biogen had a +38.3% gain for the day on its stock. Biogen’s Alzheimer’s disease treatment was approved by the U.S. Food and Drug Administration (FDA) as part of an accelerated approval …
Continue reading “What Caught Our Attention in the Investment World? – Week of June 7-11, 2021”
By Kuldip K. Ambastha On Wednesday, August 26, 2020, the stock of Salesforce.com, Inc. (CRM) had a pop of 26.0%. The stock posted smaller positive and negative returns during other days of the trading week. Strong 2Q2020 results drove the 26.0% gain in one day. For the first time, in 2Q2020 Salesforce.com, Inc. had more …
Continue reading “What Caught Our Attention in the Investment World? – Week of August 24 – 28, 2020”
By Kuldip K. Ambastha The Dow Jones Industrial Average (DJIA) had a volatile ride this past week, due to several factors. Comments from Jerome Powell (the Chair of the U.S. Federal Reserve), GDP forecasting, unemployment rate (and jobless claims) data, and coronavirus pandemic data all played their own significant parts in the DJIA activity. The …
Continue reading “Dow Jones Index Volatility – Week of June 8 – 12, 2020”